Reported Apr 3, 2019 · Terminated

Accelerate Pheno system, with Accelerate Pheno System Software 1.2.1 - 1.3.1, PSW000012B Product Usage: The Accelerate…

Accelerate Diagnostics Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Accelerate Diagnostics Inc · 3950 S Country Club Rd Ste 470 · Tucson, AZ · 85714-2240

Is this the product you have?

  • Accelerate Pheno system, with Accelerate Pheno System Software 1.2.1 - 1.3.1
  • PSW000012B Product UsageThe Accelerate Pheno system is intended to measure signal intensity of fluorescent probes bound to nucleic acid in target and non-target organisms and to take time-lapse dark-field images of immobilized growing bacterial cells when used with Accelerate PhenoTest kits
Lot codes and dates
  • REF10401008
  • Serial Numbers

    81 of 81 codes

    • 1324
    • 1325
    • 1431
    • 1432
    • 1084
    • 1087
    • 1367
    • 1362
    • 1363
    • 1615
    • 1616
    • 1358
    • 1359
    • 1453
    • 1354
    • 1357
    • 1599
    • 1176
    • 1178
    • 1353
    • 1356
    • 1576
    • 1577
    • 1578
    • 1322
    • 1323
    • 1454
    • 1594
    • 1598
    • 1288
    • 1290
    • 1688
    • 1690
    • 1691
    • 1694
    • 1798
    • 1799
    • 1800
    • 1801
    • 1135
    • 1151
    • 1326
    • 1327
    • 1477
    • 1478
    • 1479
    • 1480
    • 1619
    • 1620
    • 1617
    • 1618
    • 1489
    • 1501
    • 1687
    • 1573
    • 1574
    • 1144
    • 1145
    • 1247
    • 1249
Amount recalled
81

Where it was sold

Why it was recalled

Rare isolates of Enterobacteriaceae may generate a susceptible meropenem Minimum Inhibitory Concentration (MIC) using the affected device and a resistant result by broth microdilution. In order to mitigate any risk associated with these rare isolates, the firm has implemented an Expert Rule that suppresses the meropenem result for isolates that display a profile consistent with those that generated a false-susceptible result. The firm has responded to this risk by implementing a set of suppression rules, in a software update, to prevent incorrect results.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Accelerate Diagnostics Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Notice updated May 21, 2021 · Data as of Sep 19, 5:29 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.